Olema Pharmaceuticals, Inc. (OLMA)
7.25
+0.14
(+1.97%)
USD |
NASDAQ |
Oct 20, 16:00
7.14
-0.11
(-1.52%)
After-Hours: 20:00
Olema Pharmaceuticals Gross Profit (TTM) : -0.451M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.451M |
| March 31, 2026 | -0.481M |
| December 31, 2025 | -0.49M |
| September 30, 2025 | -0.419M |
| June 30, 2025 | -0.471M |
| March 31, 2025 | -0.433M |
| December 31, 2024 | -0.393M |
| September 30, 2024 | -0.365M |
| June 30, 2024 | -0.36M |
| March 31, 2024 | -0.691M |
| December 31, 2023 | -1.03M |
| September 30, 2023 | -1.365M |
| June 30, 2023 | -1.693M |
| Date | Value |
|---|---|
| March 31, 2023 | -1.678M |
| December 31, 2022 | -1.658M |
| September 30, 2022 | -2.808M |
| June 30, 2022 | -2.44M |
| March 31, 2022 | -2.061M |
| December 31, 2021 | -1.663M |
| September 30, 2021 | -0.0939M |
| June 30, 2021 | -0.046M |
| March 31, 2021 | -0.017M |
| December 31, 2020 | -0.011M |
| September 30, 2020 | -0.0071M |
| June 30, 2020 | -0.005M |
| March 31, 2020 | -0.003M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| SELLAS Life Sciences Group, Inc. | 0.00 |
| Puma Biotechnology, Inc. | 173.04M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Anika Therapeutics, Inc. | 75.00M |